Artículos por temáticas

A genetic variant of HTR2C may play a role in the manifestation of Tourette syndrome.

Dehning S, Müller N, Matz J, Bender A, Kerle I, Benninghoff J, Musil R, Spellmann I, Bondy B, Möller HJ, Riedel M, Zill P.

Psychiatr Genet. 2010 Feb;20(1):35-8. doi: 10.1097/YPG.0b013e32833511ce.

White-matter abnormalities in Tourette syndrome extend beyond motor pathways.

Neuner I, Kupriyanova Y, Stöcker T, Huang R, Posnansky O, Schneider F, Tittgemeyer M, Shah NJ.

Neuroimage. 2010 Jul 1;51(3):1184-93. doi: 10.1016/j.neuroimage.2010.02.049.

Management of tics and Tourette's disorder: an update.

Bestha DP, Jeevarakshagan S, Madaan V.

Expert Opin Pharmacother. 2010 Aug;11(11):1813-22. doi: 10.1517/14656566.2010.486402. Review.

The genetics of obsessive-compulsive disorder and Tourette syndrome: an epidemiological and pathway-based approach for gene discovery.

Grados MA.

J Am Acad Child Adolesc Psychiatry. 2010 Aug;49(8):810-9, 819.e1-2. doi: 10.1016/j.jaac.2010.04.009. Review.

Treatment of tics and tourette syndrome.

Singer HS.

Curr Treat Options Neurol. 2010 Nov;12(6):539-61. doi: 10.1007/s11940-010-0095-4.

Pharmacotherapeutics of Tourette syndrome and stereotypies in autism.

Rajapakse T, Pringsheim T.

Semin Pediatr Neurol. 2010 Dec;17(4):254-60. doi: 10.1016/j.spen.2010.10.008. Review.

Botulinum toxin type A in simple motor tics: short-term and long-term treatment-effects.

Rath JJ, Tavy DL, Wertenbroek AA, van Woerkom TC, de Bruijn SF.

Parkinsonism Relat Disord. 2010 Aug;16(7):478-81. doi: 10.1016/j.parkreldis.2009.11.011.

Extrastriatal dopaminergic dysfunction in tourette syndrome.

Steeves TD, Ko JH, Kideckel DM, Rusjan P, Houle S, Sandor P, Lang AE, Strafella AP.

Ann Neurol. 2010 Feb;67(2):170-81. doi: 10.1002/ana.21809.

Severe psychosocial stress and heavy cigarette smoking during pregnancy: an examination of the pre- and perinatal risk factors associated with ADHD and Tourette syndrome.

Motlagh MG, Katsovich L, Thompson N, Lin H, Kim YS, Scahill L, Lombroso PJ, King RA, Peterson BS, Leckman JF.

Eur Child Adolesc Psychiatry. 2010 Oct;19(10):755-64. doi: 10.1007/s00787-010-0115-7.

[Multiplicity analysis on the risk factors of patients with Tourette syndrome to develop the comorbidity of attention-deficit hyperactivity disorder].

Cui YH, Zheng Y.

Zhonghua Er Ke Za Zhi. 2010 May;48(5):342-5. Chinese.

Tourette syndrome in children: an updated review.

Du JC, Chiu TF, Lee KM, Wu HL, Yang YC, Hsu SY, Sun CS, Hwang B, Leckman JF.

Pediatr Neonatol. 2010 Oct;51(5):255-64. doi: 10.1016/S1875-9572(10)60050-2. Review.

Tourette syndrome: information for school nurses.

Golder T.

J Sch Nurs. 2010 Feb;26(1):11-7. doi: 10.1177/1059840509343113.

Tourette syndrome and epilepsy: a strange case of possible sudden unexpected death.

Doherty MJ, Sloan D.

Epilepsy Behav. 2010 Feb;17(2):285-6. doi: 10.1016/j.yebeh.2009.11.007.

Nucleus accumbens deep brain stimulation did not prevent suicide attempt in tourette syndrome.

Neuner I, Halfter S, Wollenweber F, Podoll K, Schneider F.

Biol Psychiatry. 2010 Aug 15;68(4):e19-20. doi: 10.1016/j.biopsych.2010.03.001. No abstract available.

Long-term, post-deep brain stimulation management of a series of 36 patients affected with refractory gilles de la tourette syndrome.

Servello D, Sassi M, Brambilla A, Defendi S, Porta M.

Neuromodulation. 2010 Jul;13(3):187-94. doi: 10.1111/j.1525-1403.2009.00253.x.